Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBI-4000 in Axillary Hyperhidrosis
NCT02336503Phase 2Completed
- Sponsor
- Botanix Pharmaceuticals
- Start
- Mar 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sofpironium in axillary hyperhidrosis, sponsored by Botanix Pharmaceuticals. Started Mar 2015; status: completed.
02
Drugs
sofpironium
03
Conditions
axillary hyperhidrosis
Beyond the preview
Go deeper on NCT02336503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336503.